Table 4 Correlations between AQP3, UT-B (SLC14A1) gene expression and clinical data in the study group
AQP3 | UT-B (SLC14A1) | |||
|---|---|---|---|---|
R | P value | R | P value | |
Age, years | 0.10 | 0.39 | 0.01 | 0.95 |
Sodium gradient (pre-dialysis) | -0.31 | 0.04 | 0.19 | 0.77 |
Urea before hemodialysis, mg/dL | -0.22 | 0.049 | 0.08 | 0.47 |
Urea after hemodialysis, mg/dL | -0.10 | 0.39 | 0.04 | 0.71 |
Urea reduction ratio (URR), % | -0.15 | 0.20 | 0.11 | 0.35 |
Hb, g/dL | -0.06 | 0.60 | 0.15 | 0.20 |
EPO ratio, IU/kg of dry body mass | 0.03 | 0.83 | -0.03 | 0.79 |
Interdialytic weight gain IWG, % | -0.12 | 0.31 | 0.12 | 0.30 |
UF ratio—IWG/dialyser, kg/dialyser m2/h | 0.15 | 0.19 | -0.10 | 0.37 |
Hemodialysis session time, min | -0.10 | 0.37 | 0.06 | 0.62 |
Hemodialysis vintage, months | -0.04 | 0.76 | -0.13 | 0.26 |
Residual kidney function, mL/24 h | 0.15 | 0.20 | 0.14 | 0.24 |